Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre study
Authors:
- 1 June 2016
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 65 (6) , 530-537
Abstract
We characterized antibiotic resistance and virulence of uropathogenic Escherichia coli (UPEC) strains isolated from urinary tract infections (UTIs) in patients hospitalized in urology departments. A prospective multicentre study was initiated from March 2009 and lasted until February 2010 in French urology units. All patients with asymptomatic bacteriuria (ABU), acute cystitis, acute pyelonephritis or acute prostatitis in whom UPEC was detected were included. Antimicrobial resistance and virulence factors were compared among the different groups. To identify independent associations between virulence markers and the risk of UTI, we used a multivariate logistic regression. We included 210 patients (mean age: 65.8 years; 106 female). Episode of UTI was community acquired in 72.4 %. ABU was diagnosed in 67 cases (31.9 %), cystitis in 52 cases (24.7 %), pyelonephritis in 35 cases (16.7 %) and prostatitis in 56 cases (26.7 %). ABU was more frequent in patients with a urinary catheter (76.1 vs 23.9 %, P<0.001). The resistance rate was 7.6 and 24.8 % for cefotaxime and ciprofloxacin, respectively. UPEC isolated from infections belonged more frequently to phylotypes B2 and D (P =0.07). The papG allele II and papA, papC, papE, kpsMT II and iutA genes were significantly more frequent in infecting strains (P<0.05). In multivariate analysis, strains susceptible to ciprofloxacin were significantly associated with papG allele II (P=0.007), kpsMT K1 (P<0.001) and hlyA (P<0.001) compared with the ciprofloxacin-resistant strains. To the best of our knowledge, this is the first study evaluating the antibiotic resistance and virulence features of UPEC isolated from patients hospitalized in urology departments. High resistance rates were observed, notably for ciprofloxacin, highlighting the importance of a reinforced surveillance in this setting.Keywords
This publication has 30 references indexed in Scilit:
- Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan communityMicrobial Pathogenesis, 2013
- Semi-automated rep-PCR for rapid differentiation of major clonal groups of Escherichia coli meningitis strainsInternational Journal of Medical Microbiology, 2009
- Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15Journal of Antimicrobial Chemotherapy, 2009
- The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patientsJournal of Clinical Epidemiology, 2008
- Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteriaInternational Journal of Antimicrobial Agents, 2008
- Pathotyping Escherichia coli by Using Miniaturized DNA MicroarraysApplied and Environmental Microbiology, 2007
- Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemiaDiagnostic Microbiology and Infectious Disease, 2007
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase TypeEmerging Infectious Diseases, 2005
- Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2001